Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and bipolar disorder in appropriate patient populations.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and offering reliable global distribution, supported by regulatory‑approved manufacturing and comprehensive documentation for import compliance.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

- Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy. - Bipolar disorder: stabilizes mood and decreases the risk of depressive and manic episodes in adults.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Rash: mild skin eruptions or itching. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or imbalance. - Nausea: gastrointestinal upset. - Insomnia: difficulty initiating or maintaining sleep. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: agranulocytosis or aplastic anemia. - Hepatic failure: signs of liver injury. - Suicidal thoughts: emergence of depressive or suicidal ideation.

When prescribing lamotrigine, clinicians should observe several precautionary measures to minimise risk.

- Initiate therapy at low dose: start with a minimal dose and titrate gradually. - Monitor skin reactions: discontinue immediately if a rash develops. - Adjust for enzyme inducers: increase dose when co‑administered with carbamazepine, phenytoin or phenobarbital. - Avoid abrupt discontinuation: taper the dose to prevent seizure worsening. - Pregnancy: use only if benefit outweighs risk, as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase adverse effect risk.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, requiring dose reduction. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenytoin: lowers lamotrigine exposure, may necessitate dose increase. - Phenobarbital: accelerates lamotrigine metabolism, reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: estrogen‑containing pills decrease lamotrigine levels, may need dose adjustment. - Serotonergic agents: concurrent use may increase risk of serotonin syndrome, monitor patient closely.